相关实验视频
Updated: Jun 28, 2025

09:31
Touchscreen Sustained Attention Task SAT for Rats
Published on: September 15, 2017
9.8K
前额吸引力动态的胆神经调节控制空间工作记忆中的性能
Alexandre Mahrach1, David Bestue1, Xue-Lian Qi2
1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
概括
来自基底核 (NB) 的胆固醇刺激通过扩大前额叶皮层 (PFC) 中的神经调来提高工作记忆性能. 这通过吸引力动力学来实现,提高记忆精度而不是精度.
科学领域:
- 神经科学是一个神经科学.
- 计算神经科学是一种神经科学.
- 认知科学 认知科学
背景情况:
- 基底核 (NB) 的胆固醇刺激已经显示出对前额叶皮层 (PFC) 功能具有反直觉的影响.
- NB刺激提高了行为表现,扩大了神经调,但改善记忆的基本机制仍然不清楚.
研究的目的:
- 阐明胆固醇神经调节增强空间工作记忆的机制.
- 研究吸引力动态在介导神经调节对PFC神经活动和行为的影响中的作用.
主要方法:
- 利用连续撞击吸引器模型来模拟在胆固醇调制下的神经活动.
- 研究了具有离散碰撞吸引器的生物可信异质网络模型.
- 分析了神经刺激,和和网络连接等参数对记忆精度和分心能力的影响.
主要成果:
- 吸引器模型中神经刺激能力的增加扩大了调,减少了扩散,通过优先考虑记忆精度来提高任务性能.
- 吸引力动力学解释了神经调节对分心能力的差异性影响,基于分心器的接近.
- 在离散网络中,减少空间相关性和增强激发改善了记忆精度.
结论:
- 胆固醇神经调节通过扰乱PFC中的吸引力动态来控制空间工作记忆.
- 这些发现提供了对乙胆如何影响神经编码和认知表现的机制理解.
相关概念视频
Working Memory
160
Working memory refers to a combination of components, including short-term memory and attention, that allow an individual to hold information temporarily as we perform cognitive tasks. It is an essential cognitive function that enables the execution of complex tasks such as problem-solving, comprehension, and reasoning. Unlike short-term memory, which simply involves the storage of information for a brief period, working memory involves the active manipulation and processing of this...
160
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
122
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
122
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
663
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
663
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.3K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K

